AKT1 and cancer: Two fundamental signal transduction pathways that may become dysregulated in a variety of cancers are RAS/MAPK (mitogen activated protein kinase) and phosphoinositide 3-kinase (PI3K)/Akt (protein kinase B)/mTOR (mammalian target of rapamycin).